Blue Wolf sells PSG to Omnicell for $225m

Blue Wolf Capital Partners has sold Pharmaceutical Strategies Group to Omnicell Inc.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this